ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Rheumatology

Top Rheumatology Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD REARDON D.O.

Rheumatology

7,758

$747K

576
361 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

35%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 18%

$96
Average prescription price

Avg: $104

CHRISTOPHER D'ARCY M.D.

Rheumatology

6,678

$789K

664
508 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$118
Average prescription price

Avg: $104

J TODER

Rheumatology

4,281

$625K

467
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 18%

$146
Average prescription price

Avg: $104

JACK MOURAD M.D.

Rheumatology

3,901

$207K

282
191 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $104

STUART SCHWARTZ MD

Rheumatology

3,741

$395K

383
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 18%

$106
Average prescription price

Avg: $104

WENDY SILVERSMITH MD

Rheumatology

3,320

$327K

310
217 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 18%

$98
Average prescription price

Avg: $104

BERNARD ZIMMERMANN M.D.

Rheumatology

1,911

$180K

167
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 10%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 18%

$94
Average prescription price

Avg: $104

VIRGINIA PARKER MD

Rheumatology

1,617

$212K

238
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 18%

$131
Average prescription price

Avg: $104

KARMELA CHAN M.D.

Rheumatology

1,435

$94.2K

213
165 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 18%

$66
Average prescription price

Avg: $104

EDWARD LALLY MD

Rheumatology

1,152

$125K

138
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 18%

$108
Average prescription price

Avg: $104

HARALD HALL M.D.

Rheumatology

1,019

$58.4K

126
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 18%

$57
Average prescription price

Avg: $104

SASKIA COOPER

Rheumatology

888

$44.2K

65
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 18%

$50
Average prescription price

Avg: $104

BRENDA BURKE DO

Rheumatology

784

$198K

88
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 18%

$252
Average prescription price

Avg: $104

HOPE DILLON-JONES MD

Rheumatology

480

$77.1K

92
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 18%

$161
Average prescription price

Avg: $104

ANISHKA ROLLE MD

Rheumatology

416

$40.8K

120
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$98
Average prescription price

Avg: $104

ANTHONY REGINATO MD

Rheumatology

320

$23.6K

52
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$74
Average prescription price

Avg: $104

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank